Articles by tag: ipo-analysis

Anthropic IPO valuation $965 billion: bubble or breakthrough?

Analysis of Anthropic IPO at $965 billion valuation: hidden risks gross margin, tokens on Solana and strategy for going public. Learn the truth before investing.

IPO Conexeu Sciences: Nasdaq and tissue regeneration technology

Conexeu Sciences went public on Nasdaq with no revenue but with 3D-bioprinting of breast matrix. Risk analysis, regulatory contradictions, and 90-day forecast. Read.

Cerebras IPO: $4.8 billion valuation as financial engineering

Analysis of Cerebras Systems $4.8 billion IPO: why it's not about chips but financial engineering, risks for investors, and connection with OpenAI. Learn the pitfalls before trading begins.

Anthropic-SpaceX Deal: Why Musk Gave Up Colossus 1 for IPO

Strategic Alliance of Anthropic and SpaceX in 2026: 300 MW for Claude, IPO at $1.75 Trillion, and Musk's 'Kill Switch'. Find out who benefited from the largest AI deal.